![Dr. Adogwa wears blue scrubs, a scrub cab, mask and glasses while working in the operating room](https://www.uc.edu/news/articles/2024/06/n21256162/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1717610676495.jpg)
How to sleep with lower back pain
UC neurosurgeon featured in Prevention article
A majority of people have had or will have lower back pain in their life. The University of Cincinnati's Owoicho Adogwa, MD, spoke with Prevention on ways to sleep when you have lower back pain.
Adogwa said lack of sleep impairs the body's ability to heal and recover, so poor sleep can aggravate existing lower back problems.
“Sleeping on your back with a pillow under the knees helps maintain the natural curve of the spine, reducing stress on the lower back,” said Adogwa, a UC Gardner Neuroscience Institute physician researcher and assistant professor of neurosurgery in UC's College of Medicine. “Side sleeping with a pillow between the knees keeps the hips, pelvis, and spine in better alignment, minimizing strain on the lumbar region.”
Folks dealing with poor sleep may also want to take a look at their mattress, Adogwa said.
“A mattress that is too soft may cause the spine to sag, leading to poor spinal alignment and increased pressure on the lower back,” he explained. “Conversely, a mattress that is too firm may fail to support the natural curves of the spine, causing discomfort and stiffness.”
Stretches and/or yoga before bed can also "alleviate muscle tension," according to Adogwa.
Featured photo at top of Dr. Adogwa in surgery. Photo/UC Health.
Related Stories
CureToday: UC enrolling patients for glioblastoma trial
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
How to sleep with lower back pain
June 5, 2024
![Prevention logo](/content/dam/refresh/uc-news/news-icons/dark/prevention.png)
The University of Cincinnati's Owoicho Adogwa spoke with Prevention about sleep positions when you have lower back pain.
WVXU: Does your spinal fluid show if you have a tumor?
November 9, 2020
University of Cincinnati researchers are starting a clinical trial to determine if they can detect brain cancer in spinal fluid.
Dermatology Times features UC research of nail squamous cell carcinoma treatment
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
GEN News: Biomarker discovery to help predict breast cancer outcomes
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
Physics World names UC, Cincinnati Children's study among top 10 Breakthroughs of 2022
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
Healio: Sleep, diet among keys to preserving cognitive function during cancer survivorship
September 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, spoke with Healio about cognitive function during cancer survivorship.
OncLive and Targeted Oncology: Drug yields long-lasting benefits to treat PEComa tumors
March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.